Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

LHRH peptide/DBCO-PEG4-NHS ester-poly (acrylamide-co-N-azidodeca-(ethylene glycol)ethylacrylamide-co-N,N-bis(acryloyl)cystamine)-covered-tumor-targeting p53 protein nanocapsules

Based on

1 Articles
2014 Most recent source

Composition

1

tumor-selective p53

mutant S121F
Type Biomolecule
Formula
Role core
2

poly (acrylamide-co-N-azidodeca-(ethylene glycol)ethylacrylamide-co-N,N-methylenebis(acrylamide))

Type Polymer
Formula
Role layer
3

dibenzocyclooctyne-PEG4-N-hydroxysuccinimidyl ester

Type Single Compound
Formula C34H39N3O10
Role graft
4

LHRH peptide

Type Biomolecule
Formula
Role graft

Properties

Applications

Characterization

Biological effects

Biological system Test details Source
MDA-MB-231 cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • prop-2-enamide
  • N-azidodeca-(ethylene glycol)ethylacrylamide
  • N,N'-methylene-bis-acrylamide
See all (4)
  1. XcfuLLy4CY6kEcj6cTRHQPbC3fY4hMAVOWqBl2xMNBgRDYjJVf2AbvY3QPROt6fYzNElKsLX
Product

LHRH peptide/DBCO-PEG4-NHS ester-poly (acrylamide-co-N-azidodeca-(ethylene glycol)ethylacrylamide-co-N,N-bis(acryloyl)cystamine)-covered-tumor-targeting p53 protein nanocapsules

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial